{"DataElement":{"publicId":"4577527","version":"1","preferredName":"Breast Malignant Neoplasm Subtype Classification Type","preferredDefinition":"The subtype for a breast malignancy","longName":"BRE_MAL_NEO_SUB_CLASS_TYPE","context":"NRG","contextVersion":"1","DataElementConcept":{"publicId":"4577516","version":"1","preferredName":"Breast Malignant Neoplasm Subtype Classification","preferredDefinition":"Information related to the subtype of the breast malignancy","longName":"Brea_Mali_Subt_Clas","context":"NRG","contextVersion":"1","ObjectClass":{"publicId":"2411756","version":"1","preferredName":"Breast","preferredDefinition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.","longName":"C12971","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast","conceptCode":"C12971","definition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0198F493-9F65-1CFD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-25","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-09-25","modifiedBy":"ONEDATA","dateModified":"2005-09-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"4577514","version":"1","preferredName":"Malignant Neoplasm Subtype Classification","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.:A group forming a type within a larger type.:A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","longName":"C9305:C25696:C25161","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Subtype","conceptCode":"C25696","definition":"A group forming a type within a larger type.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"07839D6D-63FB-4E2E-E050-BB89AD435763","latestVersionIndicator":"Yes","beginDate":"2014-11-10","endDate":null,"createdBy":"BONANNIR","dateCreated":"2014-11-10","modifiedBy":"ONEDATA","dateModified":"2014-11-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NRG CRF:NRG Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07839D6D-640C-4E2E-E050-BB89AD435763","latestVersionIndicator":"Yes","beginDate":"2014-11-10","endDate":null,"createdBy":"BONANNIR","dateCreated":"2014-11-10","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4577518","version":"1","preferredName":"Breast Malignancy Subtype Type","preferredDefinition":"The subtype for a breast malignancy","longName":"BRE_MAL_SUB_TYPE","context":"NRG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"HER2","valueDescription":"Human Epidermal Growth Factor Receptor 2 Measurement","ValueMeaning":{"publicId":"4577520","version":"1","preferredName":"Human Epidermal Growth Factor Receptor 2 Measurement","longName":"4577520","preferredDefinition":"The determination of the amount of human epidermal growth factor receptor 2 present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Human Epidermal Growth Factor Receptor 2 Measurement","conceptCode":"C112312","definition":"The determination of the amount of human epidermal growth factor receptor 2 present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0783B094-76DA-BD19-E050-BB89AD4362D6","latestVersionIndicator":"Yes","beginDate":"2014-11-10","endDate":null,"createdBy":"BONANNIR","dateCreated":"2014-11-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0783B094-76F3-BD19-E050-BB89AD4362D6","beginDate":"2014-11-10","endDate":null,"createdBy":"BONANNIR","dateCreated":"2014-11-10","modifiedBy":"ONEDATA","dateModified":"2014-11-10","deletedIndicator":"No"},{"value":"Triple Negative Basal","valueDescription":"Three Negative Basal","ValueMeaning":{"publicId":"4577521","version":"1","preferredName":"Three Negative Basal","longName":"4577521","preferredDefinition":"A natural number greater than 2 and less than 4 and the quantity that it denotes: the sum of two and one.: Involving disadvantage or harm.: The lowest layer of a structure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Three","conceptCode":"C66834","definition":"A natural number greater than 2 and less than 4 and the quantity that it denotes: the sum of two and one.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Negative","conceptCode":"C25247","definition":"Involving disadvantage or harm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Basal","conceptCode":"C90067","definition":"The lowest layer of a structure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0783B094-7701-BD19-E050-BB89AD4362D6","latestVersionIndicator":"Yes","beginDate":"2014-11-10","endDate":null,"createdBy":"BONANNIR","dateCreated":"2014-11-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0783B094-771A-BD19-E050-BB89AD4362D6","beginDate":"2014-11-10","endDate":null,"createdBy":"BONANNIR","dateCreated":"2014-11-10","modifiedBy":"ONEDATA","dateModified":"2014-11-10","deletedIndicator":"No"},{"value":"Luminal A","valueDescription":"Luminal A Breast Carcinoma","ValueMeaning":{"publicId":"4577523","version":"1","preferredName":"Luminal A Breast Carcinoma","longName":"4577523","preferredDefinition":"A biologic subset of breast carcinoma with a unique molecular signature or expression profile, defined by high expression of genes characteristic of luminal epithelial cells, including estrogen receptors (ER), estrogen regulated protein LIV-1, and the transcription factors hepatocyte nuclear factor 3, HNF3A, XBP1, and GATA 3.  This subtype of breast cancer is associated with a good prognosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Luminal A Breast Carcinoma","conceptCode":"C53554","definition":"A biologic subset of breast carcinoma defined by high expression of genes characteristic of luminal epithelial cells, including estrogen receptor (ER), estrogen regulated protein LIV-1, and the transcription factors hepatocyte nuclear factor 3, HNF3A, XBP1, and GATA 3.  This subtype of breast cancer is associated with a good prognosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0783B094-7727-BD19-E050-BB89AD4362D6","latestVersionIndicator":"Yes","beginDate":"2014-11-10","endDate":null,"createdBy":"BONANNIR","dateCreated":"2014-11-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0783B094-7740-BD19-E050-BB89AD4362D6","beginDate":"2014-11-10","endDate":null,"createdBy":"BONANNIR","dateCreated":"2014-11-10","modifiedBy":"ONEDATA","dateModified":"2014-11-10","deletedIndicator":"No"},{"value":"Luminal B","valueDescription":"Luminal B Breast Carcinoma","ValueMeaning":{"publicId":"4577525","version":"1","preferredName":"Luminal B Breast Carcinoma","longName":"4577525","preferredDefinition":"A biologic subset of breast carcinoma with a unique molecular signature or expression profile, defined by low to moderate expression of genes characteristic of luminal epithelial cells including estrogen receptors (ER), and high expression of GGH, LAPTMB4, and CCNE1.  This subtype of breast cancer is associated with a good prognosis, although not as favorable as the luminal A subtype.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Luminal B Breast Carcinoma","conceptCode":"C53555","definition":"A biologic subset of breast carcinoma defined by low to moderate expression of genes characteristic of luminal epithelial cells including estrogen receptor (ER), and high expression of GGH, LAPTM4B, and CCNE1.  This subtype of breast cancer is associated with a good prognosis, although not as favorable as the luminal A subtype.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0783B094-774D-BD19-E050-BB89AD4362D6","latestVersionIndicator":"Yes","beginDate":"2014-11-10","endDate":null,"createdBy":"BONANNIR","dateCreated":"2014-11-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0783B094-7766-BD19-E050-BB89AD4362D6","beginDate":"2014-11-10","endDate":null,"createdBy":"BONANNIR","dateCreated":"2014-11-10","modifiedBy":"ONEDATA","dateModified":"2014-11-10","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NRG CRF:NRG Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0783B094-76C3-BD19-E050-BB89AD4362D6","latestVersionIndicator":"Yes","beginDate":"2014-11-10","endDate":null,"createdBy":"BONANNIR","dateCreated":"2014-11-10","modifiedBy":"BONANNIR","dateModified":"2014-11-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"BRE_MAL_NEO_SUB_CLASS_TYPE","type":"USED_BY","context":"CCTG"}],"ReferenceDocuments":[{"name":"Breast cancer subtype","type":"Preferred Question Text","description":"Breast cancer subtype","url":null,"context":"NRG"}],"origin":"NRG CRF:NRG Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0783B094-77EF-BD19-E050-BB89AD4362D6","latestVersionIndicator":"Yes","beginDate":"2014-11-10","endDate":null,"createdBy":"BONANNIR","dateCreated":"2014-11-10","modifiedBy":"FORMBUILDER","dateModified":"2018-07-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}